Advanced search
Publication Cover
Acta Oncologica Volume 53, 2014 - Issue 4
Journal homepage
956
Views
9
CrossRef citations to date
0
Altmetric
Letters to the Editor

Role of arterial hypertension as a predictive marker for bevacizumab efficacy in recurrent glioblastoma – a prospective analysis

Claudia C. WagnerDivision of Internal Medicine, University Hospital Zurich, Zurich, Switzerland
,
Ulrike HeldHorten Center for Patient-Oriented Research and Knowledge Transfer, University of Zurich, Zurich, Switzerland
,
Reto KofmehlHorten Center for Patient-Oriented Research and Knowledge Transfer, University of Zurich, Zurich, Switzerland
,
Edouard BattegayDivision of Internal Medicine, University Hospital Zurich, Zurich, Switzerland
,
Lukas ZimmerliDivision of Internal Medicine, University Hospital Zurich, Zurich, Switzerland
&
Silvia HoferDepartment of Oncology, University Hospital Zurich, Zurich, Switzerland
Pages 572-575 | Received 10 Sep 2013, Accepted 26 Sep 2013, Published online: 13 Nov 2013

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Maria Dinche Johansen, Thomas Urup, Camilla Bjørnbak Holst, Ib Jarle Christensen, Kirsten Grunnet, Ulrik Lassen, Søren Friis & Hans Skovgaard Poulsen. (2018) Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors. Cancer Investigation 36:9-10, pages 512-519.
Read now
Yoshitaka Narita. (2015) Bevacizumab for glioblastoma. Therapeutics and Clinical Risk Management 11, pages 1759-1765.
Read now

Articles from other publishers (7)

Kaitlin G. Scheer, Lisa M. EbertMichael S. Samuel, Claudine S. Bonder & Guillermo A. Gomez. (2023) Bevacizumab-Induced Hypertension in Glioblastoma Patients and Its Potential as a Modulator of Treatment Response. Hypertension 80:8, pages 1590-1597.
Crossref
Shohei Moriyama, Michinari Hieda, Megumi Kisanuki, Shotaro Kawano, Taku Yokoyama, Mitsuhiro Fukata, Hitoshi Kusaba, Toru Maruyama, Eishi Baba, Koichi Akashi & Haruhisa Fukuda. (2022) Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy. Circulation Journal.
Crossref
Kokab Irfan Khan, Prasana Ramesh, Suthasenthuran Kanagalingam, FNU Zargham Ul Haq, Nishok Victory Srinivasan, Aujala Irfan Khan, Ghadi D Mashat, Mohammad Hazique & Safeera Khan. (2022) Bevacizumab-Induced Hypertension as a Potential Physiological Clinical Biomarker for Improved Outcomes in Patients With Recurrent Glioblastoma Multiforme: A Systematic Review. Cureus.
Crossref
Elisabeth Bumes, Sarah Rzonsa, Markus Hutterer, Martin Proescholdt, Ulrich Bogdahn, Markus J. Riemenschneider, Martin Uhl, Christina Wendl & Peter Hau. (2015) Adverse event grading following CTCAE v3.0 underestimates hypertensive side effects in patients with glioma treated with Bevacizumab. Journal of Neuro-Oncology 127:1, pages 191-200.
Crossref
Diana Moreno-Muñoz, Juan R. de la Haba-Rodríguez, Francisco Conde, Laura M. López-Sánchez, Araceli Valverde, Vanessa Hernández, Antonio Martínez, Carlos Villar, Auxiliadora Gómez-España, Ignacio Porras, Antonio Rodríguez-Ariza & Enrique Aranda. (2015) Genetic variants in the renin-angiotensin system predict response to bevacizumab in cancer patients. European Journal of Clinical Investigation 45:12, pages 1325-1332.
Crossref
Weijuan Li, Kevin Croce, David P. Steensma, David F. McDermott, Ori Ben-Yehuda & Javid Moslehi. (2015) Vascular and Metabolic Implications of Novel Targeted Cancer Therapies. Journal of the American College of Cardiology 66:10, pages 1160-1178.
Crossref
. (2015) Bevacizumab. Reactions Weekly 1545:1, pages 56-56.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.